In recent years, China's in vitro diagnostics (IVD) market has experienced explosive growth.
According to statistics from the VCBeat Orange Database, there have been 56 financing deals in China’s IVD sector from 2022 through May 1. Amid the fervor in this track, routine urinalysis, as a barometer of human health and an optimal vehicle for non-invasive and painless testing, has become one of the focal points drawing industry attention.
Urine, as the body’s primary “liquid code,” contains a wealth of information reflecting disease risk, dietary patterns, physical activity levels, medication use, and alcohol consumption. Up to 7,206 indicators can be detected in urine, including numerous tumor markers, with more than 250 currently applicable in clinical practice. As technology advances, the secrets held within urine are being gradually unlocked.
Currently, most people undergo routine urinalysis as part of their annual health checkups. However, the sample collection process is often non-standardized, and the results only reflect short-term health status. Consequently, current practices are far from sufficient in terms of both serving the broader digital health market and achieving widespread adoption of routine urinalysis.
With the widespread adoption of smart toilets in millions of households and advancements in technology, urinalysis can now be performed at home. By leveraging artificial intelligence algorithms for timely detection and analysis of health indicators, these systems provide early health warnings, becomingChongqing Defang Technology Co., Ltd.(hereinafter referred to as“Defang Technology”) major innovation.
Defang Technology isA technology-driven enterprise integrating the R&D, manufacturing, sales, and after-sales services of home-based health IoT products and associated consumables, with strategic development focused on the broader health industry and big data informatics.The company has been honored with the titles of “Outstanding Service Provider in China’s Intelligent Technology Industry” and “Most Influential Brand in China’s Independent Innovation.”“Model Enterprise of the Healthy China Project Management Committee,”“Awards including Third Prize in the 3rd China Medical Device Innovation and Entrepreneurship Competition, Third Prize in the 3rd Central State-Owned Enterprises Yixing Innovation and Creativity Competition, and recognition as a Chongqing Intellectual Property Advantage Enterprise.” Notably, the “3rd Central State-Owned Enterprises Yixing Innovation and Creativity Competition” was hosted by the State-owned Assets Supervision and Administration Commission of the State Council. Defang Technology underwent rigorous selection over two years, from preliminary rounds and semifinals to the finals, ultimately earning high acclaim from expert judges for its innovative product capabilities.

Defang Technology Wins Third Prize at the “3rd Central State-Owned Enterprise Yixing Innovation and Creativity Competition”

Defang Technology's Health Smart Inspection Products
For C-end users, Defang Technology has launched"Defang Intelligent Health Checkup Robot" Smart Toilet for Health Monitoring, this is independently developed and innovated by Defang TechnologyNext-Generation Smart Products. By integrating medical-grade dry chemistry colorimetry with artificial intelligence, the core technology enables non-invasive, zero-contact, fully automated collection of human urine and other samples, and leverages AI to detect, analyze, and interpret health indicators. Through continuous sampling, testing, and analysis, it generates visualized big data on human health, thereby facilitating personal health assessment, disease early warning, medication monitoring, and support for precision treatment.
Defang Intelligent Physical Examination RobotThe innovative technological application involves embedding Defang Technology’sExclusive Patented Urine Testing Module Chip, enabling fully automated, non-intrusive precise sample collection, contamination-free transport, and intelligent detection and analysis. The entire process requires no complex operations and keeps hands clean.

“Defang Intelligent Health Checkup Robot” Product Illustration

One-Touch FingerprintThat's it.Enable Health Monitoring
The product is intelligent and convenient to use. Before use, users scan the QR code inside the toilet seat cover with their mobile phone to bind personal and family information, enabling shared use by the entire household on a single device. During use, onlyFingerprint Recognition, normal toileting enables automatic urine collection by the sampling rod. After the urine sample is extracted, it is transmitted through a dedicated sterile channel to the chip cartridge for automated testing, with triple-layer medical-grade hypochlorous acid deep-coverage disinfection implemented.Zero sample contamination, ensuring test accuracy. Upon completion of the test, the smart diagnostic toilet will automatically dispose of the test strip and flush and disinfect the bowl.
Urinalysis Module Chip in2 Minuteswithin, leukocytes, urinary glucose, microalbumin, bilirubin, etc. can be tested14 Key Routine Urinalysis ParametersAI-powered computation and analysis, ultimately presenting changes in user test data visually through the Defangyun Mini Program/App, along with corresponding health alerts and recommendations. Fully equipped withVisualization of Health Data, Controllability of Health Management, and Rationalization of Health Careadvantages and development characteristics.

In addition,Defang Cloud Big Health PlatformAs an AI-powered cloud computing platform for human vital data, independently developed and designed by Defang Technology, it offers rich functionalities. It not only generates personalized health management profiles for users but also integratesScience Popularization, Search, Services, Mallsuch functions, forming a commercial closed loop from detection to service delivery and providing diversified health services.
Currently, the urine detection module DF-UTM0101 embedded in the Defang Intelligent Physical Examination Robot is an original innovation of Defang Technology.New-Generation Urine Testing Biochip Module. ItMedical-grade dry chemistry colorimetryandPrecision Medicine Researchas the core technology, integrating cutting-edge technologies such as IoT, cloud computing, and big data, primarily serving as the foundational hardware for smart health-monitoring toilets.

Urine Testing Module DF-UTM0101
The urine test module integrates14-Parameter Urinalysis Function, Standardized Interface, Ultra-Compact and Lightweight for Easier Integration. Equipped with exclusiveDefang Cloud Software Management System, enabling effective monitoring of users' health data anytime and anywhere, with real-time remote solution upgrades, data sharing, and service support.
Leveraging the aforementioned hardware products and software services, Defang Technology tailors personalized health solutions to meet the diverse needs of its B2B clients.
For bathroom fixture manufacturers,The urine testing module can be purchased separately and integrated into the toilet seat, enabling product upgrades with urine analysis capabilities and enhancing product value-added services.For healthcare institutions,Defang Technology provides a comprehensive, customer-centric solution encompassing “smart testing terminals + software data services,” and can also tailor offerings to meet partners’ specific needsCustomized Comprehensive Healthcare Solutions.Its accumulated user data not only forRefined User Operations for Enterpriseslaid a solid foundation, and alsoCorporate Strategic Decision-Making GuidanceProvided direction.

A Showcase of Defang Technology’s Patents: Comprehensive Technical Patents Build the Company’s Moat
Defang Technology has not forgotten to build a patent moat while developing its products. Currently, the company hasOver 100 patents, including more than 50 utility model patents and over 30 software copyrights.
Defang Technology’s remarkable achievements are inextricably linked to its core management team.
The core management team of Defang Technology comprises chief experts from Grade 3A hospitals with extensive clinical experience, university professors who possess strategic insights in clinical medicine and medical laboratory science, and industry veterans who have held executive positions at renowned pharmaceutical companies such as Pfizer, Merck & Co., and Yangtze River Pharmaceutical Group. With decades of experience in the healthcare sector, these leaders have not only achieved mastery in their respective specialties but also accumulated substantial resources and unique perspectives on industry trends and technologies, thereby establishing formidable intangible knowledge and technological barriers for Defang Technology.
Meanwhile, to refine the technical excellence of its products, Defang Technology has established an expert team focusing on two directions: “basic research” and “medical applications.” This team comprises top scientists and hospital experts, including professors from Stanford University, professors from the College of Life Sciences at Beijing Normal University, experts from Beijing Tiantan Hospital, and professors from the Army Medical University.Advisory Team.
According to founder Li Chunlin, Defang Technology has partnered with more than 20 organizations, including a certain real estate company, a Shanghai-based health and elderly care institution, and community hospitals. This year, it has also collaborated with offline pharmacies such as Tongjun Ge, Cardinal Health, and Heping Pharmacy.Building Smart Health Check-up Stations in Offline Residential Communities,Concurrently signed agency agreements with multiple powerful distributors.
Defang Technology currently mainly throughDirect product sales; sales of test strips and disinfectant consumables; collaboration with bathroom fixture manufacturers on testing modules; partnerships with community hospitals and large-scale health industry institutionsand other means to generate profits.
Defang Technology's FlagshipSelf-developed, and withSinopharm, Foxconn, Sichuan Changhongand other enterprises to engage in industrial collaboration; withStanford University, Peking University, Zhejiang University, Chongqing Medical University, Army Medical UniversityCollaborate with leading universities on academic initiatives, thereby establishing an integrated innovation value chain encompassing industry, academia, and research.
Li Chunlin stated that Defang Technology currently has two areas of need. One isTalent Demand, we hope to attract more talent in strategic management, product technology, medicine, and market operations to join the company; on the other hand, the company isSeeking Financing, to support product iteration plans aimed at enabling the detection of over 256 urine parameters, as well as market promotion and other initiatives.